Risk of venous thromboembolism in patients with splenic injury and splenectomy

Summary

The spleen is a crucial organ in humans. However, little is known about the association of venous thromboembolism (VTE) with splenic injury and splenectomy in trauma patients. The aim of this study was to determine the subsequent risk of VTE following splenic injury and splenectomy. A nationwide retrospective cohort study was conducted by analysing data from the National Health Insurance Research Database in Taiwan. We included 6,162 splenic injury patients (3,033 splenectomised and 3,129 nonsplenectomised patients) and 24,648 comparison patients who were selected by frequency match based on sex, age, and the index year during 2000–2006. All patients were followed until the occurrence of VTE, 31 December, 2011, death, or withdrawal from the insurance program. The age of patients with splenic injury was 41.93 ± 16.44 years. The incidence rates of VTE were 11.81, 8.46, and 5.21 per 10,000 person-years in the splenic injury patients with splen -ectomy, splenic injury patients without splenectomy, and comparison patients, respectively. Compared with the comparison cohort, splenic injury patients with splenectomy exhibited a 2.21-fold risk of VTE (95 % confidence interval [CI], 1.43–3.43), whereas those without splenectomy exhibited a 1.71-fold risk of VTE (95 % CI, 1.05–2.80). The overall incidence rate of VTE was 1.97-fold higher in the splenic injury cohort than the comparison cohort (95 % CI, 1.38–2.81). Although splenectomy increased the risk of VTE 1.35-fold compared with no splenectomy, the difference was not statistically significant (95 % CI, 0.74–2.45). These results may alert physicians and patients to the complications of splenic injury and splenectomy.

Keywords

Deep-vein thrombosis - portal vein thrombosis - pulmonary embolism - splenectomy - splenic injury - venous thromboembolism

• References

• 1 Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet 2011; 378: 86-97.
• 2 Oida T, Kano H, Mimatsu K. et al. Thrombocytosis following splenectomy: with or without additional organ resection. Hepatogastroenterology 2012; 59: 1033-1035.
• 3 Crary SE, Buchanan GR. Vascular complications after splenectomy for haematologic disorders. Blood 2009; 114: 2861-2868.
• 4 DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 2007; 13: 1-209.
• 5 Rose AT, Newman MI, Debelak J. et al. The incidence of splenectomy is decreasing: lessons learned from trauma experience. Am Surg 2000; 66: 481-486.
• 6 Zonies D, Eastridge B. Combat management of splenic injury: trends during a decade of conflict. J Trauma Acute Care Surg 2012; 73: S71-74.
• 7 Raikhlin A, Baerlocher MO, Asch MR. et al. Imaging and transcatheter arterial embolisation for traumatic splenic injuries: review of the literature. Can J Surg 2008; 51: 464-472.
• 8 Rosati C, Ata A, Siskin GP. et al. Management of splenic trauma: a single institution’s 8-year experience. Am J Surg 2014; 209: 308-314.
• 9 Hommes M, Navsaria PH, Schipper IB. et al. Management of blunt liver trauma in 134 severely injured patients. Injury 2014; 46: 837-842.
• 10 Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107: I9-16.
• 11 Kristinsson SY, Gridley G, Hoover RN. et al. Long-term risks after splenectomy among 8, 149 cancer-free American veterans: a cohort study with up to 27 years follow-up. Haematologica 2014; 99: 392-398.
• 12 Dawson AA, Bennett B, Jones PF. et al. Thrombotic risks of staging laparotomy with splenectomy in Hodgkin’s disease. Br J Surg 1981; 68: 842-845.
• 13 Borgna Pignatti C, Carnelli V, Caruso V. et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 1998; 99: 76-79.
• 14 Schilling RF, Gangnon RE, Traver MI. Delayed adverse vascular events after splenectomy in hereditary spherocytosis. J Thromb Haemost 2008; 06: 1289-1295.
• 15 Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect 2001; 43: 182-186.
• 16 Stamou KM, Toutouzas KG, Kekis PB. et al. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 2006; 141: 663-669.
• 17 Jaïs X, Ioos V, Jardim C. et al. Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax 2005; 60: 1031-1034.
• 18 Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
• 19 Charlson ME, Pompei P, Ales KL. et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
• 20 Dendle C, Spelman T, Sundararajan V. et al. An analysis of the thromboembolic outcomes of 2472 splenectomised individuals. Blood 2015; 125: 1681-1682.
• 21 White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-8.
• 22 White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998; 128: 737-740.
• 23 Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 2000; 85: 1334-1337.
• 24 Qi X, Ren W, Guo X. et al. Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis. Intern Emerg Med 2015; 10: 205-217.
• 25 Winslow ER, Brunt LM, Drebin JA. et al. Portal vein thrombosis after splenectomy. Am J Surg 2002; 184: 631-635.
• 26 Vecchio R, Cacciola E, Cacciola RR. et al. Portal vein thrombosis after laparoscopic and open splenectomy. J Laparoendosc Adv Surg Tech A 2011; 21: 71-75.
• 27 Van Haren RM, Valle EJ, Thorson CM. et al. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism. J Trauma Acute Care Surg 2014; 76: 443-449.
• 28 Brakenridge SC, Henley SS, Kashner TM. et al. Inflammation and the Host Response to Injury Investigators.. Comparing clinical predictors of deep venous thrombosis versus pulmonary embolus after severe injury: a new paradigm for posttraumatic venous thromboembolism?. J Trauma Acute Care Surg 2013; 74: 1231-1237.
• 29 Thomsen RW, Schoonen WM, Farkas DK. et al. Risk of venous thromboembolism in splenectomised patients compared with the general population and appendectomised patients: a 10-year nationwide cohort study. J Thromb Haemost 2010; 08: 1413-1416.
• 30 Kim JYS, Khavanin N, Rambachan A. et al. Surgical duration and risk of venous thromboembolism. J Am Med Assoc Surg 2015; 150: 110-117.
• 31 Kimmell KT, Jahromi BS. Clinical factors associated with venous thromboembolism risk in patients undergoing craniotomy. J Neurosurg 2014; 1-8.
• 32 Tominaga H, Setoguchi T, Tanabe F. et al. Risk factors for venous thromboembolism after spine surgery. Medicine 2015; 94: e466.
• 33 Boxer MA, Braun J, Ellman L. Thromboembolic risk of postsplenectomy thrombocytosis. Arch Surg 1978; 113: 808-809.
• 34 Visudhiphan S, Ketsa-Ard K, Piankijagum A. et al. Blood coagulation and platelet profiles in persistent post-splenectomy thrombocytosis. The relationship to thromboembolism. Biomed Pharmacother 1985; 39: 264-271.
• 35 Troendle SB, Adix L, Crary SE. et al. Laboratory markers of thrombosis risk in children with hereditary spherocytosis. Pediatr Blood Cancer 2007; 49: 781-785.
• 36 Goldfarb AW, Rachmilewitz EA, Eisenberg S. Abnormal low and high density lipoproteins in homozygous beta-thalassaemia. Br J Haematol 1991; 79: 481-486.
• 37 Cheng CL, Kao YH, Lin SJ. et al. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011; 20: 236-242.
• 38 Yu YB, Gau JP, Liu CY. et al. A nation-wide analysis of venous thromboembolism in 497, 180 cancer patients with the development and validation of a risk-stratification scoring system. Thromb Haemost 2012; 108: 225-235.